跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,972 条关于
“HSD1 inhibitor”
全部
19,972
临床试验
9,809
药物
4,086
机构
20
资讯
6,057
上个月
Sparrow Pharmaceuticals Bets Cortisol, Not GLP-1, Is the Next Frontier in Type 2 Diabetes
2个月前
Emestedastat Shows Late-Emerging Antidepressant Signal in Difficult-to-Treat MDD Despite Missing Cognitive Endpoint
去年
Actinogen's Xanamem (Emestedastat) Receives WHO Recognition and Advances in Alzheimer's Trials
14年前
GIP Reduces Free Fatty Acids via 11β-HSD1 Inhibition in Adipose Tissue
2年前
Merck's Bomedemstat Shows Promise as Irreversible LSD1 Inhibitor for MPNs
9个月前
Actinogen Completes Enrollment in Pivotal Alzheimer's Trial with 247 Participants
2年前
Actinogen Optimizes XanaMIA Phase 2b Alzheimer's Disease Trial Design
去年
Gilteritinib Shows Promise as ALK Inhibitor in Acute Myeloid Leukemia
去年
Oryzon Receives EMA Approval for First LSD1 Inhibitor Trial in Sickle Cell Disease
2年前
FDA Approves Resmetirom (REZDIFFRA™) as First Treatment for NASH
第 1 页,共 606 页
上一页
下一页